liver cancer
FDA Clears Lion TCR to Begin Phase II Trial of TCR T-Cell Therapy in HBV-Related Liver Cancer
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.
Senti Biosciences, Celest Therapeutics Treat First Patient With CAR-NK Cell Therapy in China
The firms have teamed up on a Phase I trial to evaluate the off-the-shelf cell therapy SN301A in patients with advanced GPC3-expressing liver cancers.
Quest's Haystack Oncology, U of Montreal to Study Liquid Biopsy MRD Test in Colorectal Cancer
The partners will use Haystack's MRD test to assess treatment response and detect early relapse in colorectal cancer patients with liver metastasis.
GC Cell, Lukas Biomedical Team up to Advance Autologous Cell Therapies
The Korean and Taiwanese biotechs will share research and collaborate on clinical trials to bring their cell therapies to more patients in Southeast Asia and globally.